Market
Anaconda Biomed raises $56m for catheter portfolio’s advance
Anaconda Biomed secured $56 million in funding to advance its catheter portfolio and support clinical development, including completion of a pivotal IDE study. The capital will accelerate the company's pipeline toward regulatory approval and commercialization.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network